Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents… (NCT07533890) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease
40 participantsStarted 2026-04
Plain-language summary
In this study the intestinal microbiome and metabolic profiles of patients with inflammatory bowel disease will be determined upon probiotic intervention.
Who can participate
Age range5 Years – 18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Signed informed consent
* Diagnosis of inflammatory bowel disease according to actual guidelines (Porto Criteria)
* General good health
* Ability to understand and follow study procedures and understand informed consent
* Age 5 -18 years
* No probiotic therapy 4 weeks before entering into the study.
Exclusion Criteria:
* Participation in other clinical studies interfering with study procedures.
* Inability or contraindications to undergo the investigated intervention
* Severe or acute flare of disease (for UC PUCAI score ≥35, for CD wPCDAI \>40)
* Treatment escalation within last 4 weeks for uncontrolled disease.
* Antibiotic or probiotic therapy within the last 4 weeks.